Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Barrier Immunity|May 20, 2026
Novel Organelle-Based Intracellular Immunity with Mechanistic and Therapeutic ImplicationsKeman Xu, Shih-Yu Hung, Fatma Saaoud, et al.
Oncoimmunology|March 3, 2020
Overexpression of microRNA-155 enhances the efficacy of dendritic cell vaccine against breast cancerJohnie Hodge, Fang Wang, Junfeng Wang, et al.
Pharmacology & Therapeutics|November 3, 2020
Circular RNAs are a novel type of non-coding RNAs in ROS regulation, cardiovascular metabolic inflammations and cancersFatma Saaoud, Charles Drummer I V, Ying Shao, et al.
Frontiers in Medicine|February 13, 2026
Chronic obstructive pulmonary disease reprograms the lung into an immune organ through trained immunity, cell death networks, and immune checkpoint dysregulationFatma Saaoud, Keman Xu, Yifan Lu, et al.
International Journal of Drug Discovery and Pharmacology|February 10, 2025
Immune Checkpoints Are New Therapeutic Targets in Regulating Cardio-, and Cerebro-Vascular Diseases and CD4+Foxp3+ Regulatory T Cell ImmunosuppressionYing Shao, William Y Yang, Gayani Nanayakkara, et al.
Redox Biology|June 26, 2023
Early hyperlipidemia triggers metabolomic reprogramming with increased SAH, increased acetyl-CoA-cholesterol synthesis, and decreased glycolysisKeman Xu, Fatma Saaoud, Ying Shao, et al.
Journal of Cellular and Molecular Medicine|November 19, 2020
MiR155 modulates vascular calcification by regulating Akt-FOXO3a signalling and apoptosis in vascular smooth muscle cellsYong Li, Wei Sun, Fatma Saaoud, et al.
Redox Biology|October 1, 2021
Procaspase-1 patrolled to the nucleus of proatherogenic lipid LPC-activated human aortic endothelial cells induces ROS promoter CYP1B1 and strong inflammationYifan Lu, Gayani Nanayakkara, Yu Sun, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 3, 2022
Monocyte Adhesion Assays for Detecting Endothelial Cell Activation in Vascular Inflammation and AtherosclerosisKeman Xu, Fatma Saaoud, Stephanie Yu, et al.
Frontiers in Cardiovascular Medicine|December 11, 2024
Perspective: Pathological transdifferentiation-a novel therapeutic target for cardiovascular diseases and chronic inflammationWilliam Y Yang, Mohammed Ben Issa, Fatma Saaoud, et al.
Pageof 6